References
Ahearn, J. M., Provost, T. T., Dorsche, C. A., Stevens, M. B., Bias, W. B., and Arnett, F. C.: Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression and clinical features in systemic lupus erythematosus. Arthritis Rheum 25: 1031–1040, 1982
Bell, D. A. and Maddison, P. J.: Serologic subsets in systemic lupus erythematosus: an evaluation of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 23: 1268–1271, 1980
Benaceraff, B.: Role of MHC gene products in immune regulation. Science 212: 1229–1238, 1981
Ben-Chetrit, E., Chan, E. K. L., Sulivan, K. F., and Tan, E. M.: A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 167: 1560–1571, 1988
Ben-Chetrit, E., Gandy, B. J., Tan, E. M., and Sullivan, K. F.: Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. J Clin Invest 83: 1284–1292, 1989
Black, C. M., Maddison, P. J., Welsh, K. I., Bernstein, R. C., Woodrow, J. C., and Pereira, R. S.: HLA and Immunoglobulin allotypes in mixed connective tissue disease. Arhtritis Rheum 31: 131–134, 1988
Bodmer, J. H., Marsch, S. G. E.,Parham, P., Erlich, H. A., Albert, E., Bodmer, W. F., Dupont, B., Mach, B., Mayr, W. R., Sasazuki, T., Schreuder, G. M. Th., Strominger, J. L., Svejgaard, A., and Terasaki, P. I.: Nomenclature for factors of the HLA system, 1989. Tissue Antigens 35: 1–8, 1990
Brown, J. H., Jardetzky, T., Saper, M. A., Samaroui, B., Bjorkman, P. J., and Wiley, D. C.: A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules. Nature 332: 845–850, 1988
Buyon, J. P., Ben-Cherit, E., Karp, S., Rouby, R. A. S., Pompeo, L., Reeves, W. H., Tan, E. M., Winchester, R.: Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 84: 627–634, 1989
Dunckley, H., Gatenby, P. A., and Serjeantson, S. W.: DNA typing of HLA-DR antigens in systemic lupus erythematosus. Immunogenetics 24: 158–162, 1986
Fielder, A. H. L., Walport, M. J., Batchelor, J. R., Rynes, R. I., Black, C. M., Dodi, I. A., and Hughes, G. R. V.: Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining dissease susceptibility. Brit Med J 286: 425–428, 1983
Goldberg, M. A., Arnett, F. C., Bias, W. B., and Shulman, L. E.: Histocompatibility antigens in systemic lupus erythematosus. J Exp Med 148: 1728–1732, 1976
Guldner, H. H., Netter, H. J., Szostecki, C., Lakomek, H.J., and Will, H.: Epitope mapping with a recombinant human 68-kDa (Ul) ribonucleoprotein antigen reveals heterogenous autoantibody profiles in human autoimmune sera. J Immunol 141: 469–475, 1988
Hamilton, R. G., Harley, J. B., Bias, W. B., Roebber, M., Reichlin, M., Hochberg, M. C., and Arnett, F. C.: Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 31: 496–505, 1988
Lerner, M. R., Boyle, J., Mount, S., Wolin, S., and Steitz, J. A.: Are snRNPs involved splicing? Nature 283: 220–224, 1980
Maddison, P. J., Isenberg, D. A., Goulding, N. J., Leddy, J., and Skinner, R. P.: Anti-La (SSB) identifies a distinctive subgroup of systemic lupus erythematosus. Brit J Rheumatol 27: 27–31, 1988
McHugh, N. J., James, I. E., and Maddison, P. J.: Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease. Clin Exp Immunol 72: 457–464, 1988
Noreen, H. J., Davidson, M. L., McCullough, J., Bach, F. H., and Segall, M.: HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients. Transplant Proc 21: 2968–2970, 1989
Query, C. C. and Keene, J. D.: A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 51: 211–220, 1987
Rader, M. D., O'Brien, C., Liu, Y., Harley, J. B., and Reichlin, M.: Heterogeneity of the Ro/SSA antigen. J Clin Invest 83: 1293–1298, 1989
Stephens, H. A. F., Sakkas, L. I., Vaughan, R. W., Teitsson, I., Welsh, K. I., and Panayi, G. S.: HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis. Immunogenetics 30: 119–122, 1989
Tan, E. M.: Antibodies to nuclear antigens (ANA): their immunology and medicine. Adv Immunol 33: 167–240, 1982
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. F., McShane, D., Rothfield, N. F., Schaller, J. F., Talal, N., and Winchester, R.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277, 1982
Todd, J., Acha-Orbea, H., Bell, J. I., Chao, N., Fronek, Z., Jacob, C. O., McDermott, M., Sinha, A. A., Timmerman, L., Steinman, L., and McDevitt, H. O.: A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003–1009, 1988
Wasicek, C. A. and Reichlin, M.: Clinical and serological differences between systemic lupus erythematosus patients and antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 69: 835–843, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stephens, H.A.F., McHugh, N.J., Maddison, P.J. et al. HLA class II restriction of autoantibody production in patients with systematic lupus erythematosus. Immunogenetics 33, 276–280 (1991). https://doi.org/10.1007/BF00230506
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00230506